Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer

Colorectal cancer is one of the leading causes of cancer deaths worldwide. Due to targeted therapy, overall survival (OS) of metastatic colorectal cancer (mCRC) patients has been significantly increased over the past decade. However, the best sequencing of the therapeutic agents to be used in RAS wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Tianzhu, Chen, Wensen, Li, Ping, Sun, Jing, Gu, Yanhong, Chen, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784580/
https://www.ncbi.nlm.nih.gov/pubmed/29403291
http://dx.doi.org/10.2147/OTT.S149110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784580/
https://www.ncbi.nlm.nih.gov/pubmed/29403291
http://dx.doi.org/10.2147/OTT.S149110

Ejemplares similares